- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medeon Biodesign (6499)
The Medeon Biodesign share price today is 60.00, view TWO 6499 stock exchange data. Track the latest Medeon Biodesign share price with real-time updates on 6499 stock performance including market cap, day range, 52-week range and dividend yield. Access 6499 charts, earnings dates and analyst estimates to support your investment decisions.
TPEX
Currency in TWD
60.00
+2.50(+4.35%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57.50
60.00
52 wk Range
55.80
134.00
6499 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57.5060.00
52 wk Range
55.80134.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6499 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
200.00
Upside
+233.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 200.00
(+233.33% Upside)
Earnings
Latest Release
10-08-2026
EPS / Forecast
-- / -1.80
Revenue / Forecast
-- / 121M
Compare 6499 to Peers and Sector
Metrics to compare | 6499 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6499PeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.5x | 3.0x | −0.4x | |
PEG Ratio | −0.41 | −1.72 | 0.00 | |
Price/Book | 4.3x | 4.8x | 2.6x | |
Price / LTM Sales | 13.5x | 7.5x | 3.1x | |
Upside (Analyst Target) | 233.3% | 100.9% | 48.2% | |
Fair Value Upside | Unlock | 5.4% | 5.8% | Unlock |
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Medeon Biodesign (6499) Share Price Today?
The Medeon Biodesign share price today is 60.00.
What is the current Medeon Biodesign (6499) share price and day range?
As of 11-08-2026, the Medeon Biodesign share price is 60.00, with a previous close of 48.70. The share price has ranged from 57.50 to 60.00 today, while the 52-week range spans from 55.80 to 134.00.
What Is the Medeon Biodesign Market Cap?
As of today, Medeon Biodesign market cap is 5.82B.
What Is the Medeon Biodesign (6499) Share Price Target?
The average 12-month share price target for Medeon Biodesign is 200.00, with a high estimate of 200 and a low estimate of 200. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +233.33% Upside potential.
What Is Medeon Biodesign's Earnings Per Share (TTM)?
The Medeon Biodesign EPS (TTM) is -6.55.
When Is the Next Medeon Biodesign Earnings Date?
Medeon Biodesign will release its next earnings report on 29-10-2026.
From a Technical Analysis Perspective, Is 6499 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Medeon Biodesign Trade On?
Medeon Biodesign is listed and trades on the Taipei Exchange.
What Is the Stock Symbol for Medeon Biodesign?
The stock symbol for Medeon Biodesign is "6499."
How Many Times Has Medeon Biodesign Stock Split?
Medeon Biodesign has split 7 times.
How Many Employees Does Medeon Biodesign Have?
Medeon Biodesign has 39 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.